We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.96B
AUM Growth
+$565M
Cap. Flow
-$238M
Cap. Flow %
-2.66%
Top 10 Hldgs %
14.1%
Holding
748
New
26
Increased
189
Reduced
394
Closed
36

Top Buys

Rank Stock Value
1
STAG icon
STAG Industrial
STAG
+$26.5M
2
CRI icon
Carter's
CRI
+$23.3M
3
HWC icon
Hancock Whitney
HWC
+$19.5M
4
UL icon
Unilever
UL
+$16.7M
5
MTDR icon
Matador Resources
MTDR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Industrials 16.66%
3 Technology 16.47%
4 Financials 13.37%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
176
Integra LifeSciences
IART
$1.29B
$14.1M 0.16%
252,205
+14,274
+6% +$727K
TGT icon
177
Target
TGT
$65.6B
$14M 0.16%
93,842
-3,760
-4% -$590K
MCD icon
178
McDonald's
MCD
$192B
$13.9M 0.15%
52,567
-3,652
-6% -$963K
MTDR icon
179
Matador Resources
MTDR
$6.2B
$13.8M 0.15%
+241,327
New +$15.2M
WEC icon
180
WEC Energy
WEC
$35.7B
$13.8M 0.15%
146,738
+192
+0.1% +$17.7K
ACN icon
181
Accenture
ACN
$102B
$13.7M 0.15%
51,396
+591
+1% +$163K
MMM icon
182
3M
MMM
$90.9B
$13.6M 0.15%
135,977
-13,277
-9% -$1.35M
ENV
183
DELISTED
ENVESTNET, INC.
ENV
$13.4M 0.15%
217,836
+14,742
+7% +$785K
CTAS icon
184
Cintas
CTAS
$81.9B
$13.4M 0.15%
118,888
-584
-0.5% -$63.2K
ALKS icon
185
Alkermes
ALKS
$8.22B
$13.4M 0.15%
511,235
+65,568
+15% +$1.57M
NOVT icon
186
Novanta
NOVT
$5.08B
$13.2M 0.15%
97,209
+16,819
+21% +$2.35M
FR icon
187
First Industrial Realty Trust
FR
$8.73B
$13.1M 0.15%
271,710
+66,366
+32% +$3.17M
CIEN icon
188
Ciena
CIEN
$53.4B
$13M 0.15%
255,241
+114,672
+82% +$5.18M
ITT icon
189
ITT
ITT
$17.5B
$13M 0.14%
160,009
-7,488
-4% -$580K
CMCO icon
190
Columbus McKinnon
CMCO
$553M
$12.8M 0.14%
394,720
-3,513
-0.9% -$104K
OPCH icon
191
Option Care Health
OPCH
$3.45B
$12.4M 0.14%
411,390
+28,498
+7% +$885K
PGR icon
192
Progressive
PGR
$123B
$12.3M 0.14%
95,088
-631
-0.7% -$80K
ORCL icon
193
Oracle
ORCL
$374B
$12.1M 0.14%
147,933
-1,328
-0.9% -$101K
MD icon
194
Pediatrix Medical
MD
$2.18B
$12.1M 0.13%
812,912
-7,580
-0.9% -$124K
GWW icon
195
W.W. Grainger
GWW
$65.3B
$12M 0.13%
21,611
-724
-3% -$409K
LKQ icon
196
LKQ Corp
LKQ
$5.68B
$11.8M 0.13%
221,235
-15,816
-7% -$836K
WK icon
197
Workiva
WK
$3.36B
$11.7M 0.13%
139,656
+8,671
+7% +$672K
LOW icon
198
Lowe's Companies
LOW
$117B
$11.6M 0.13%
58,156
-409
-0.7% -$81.7K
UPS icon
199
United Parcel Service
UPS
$88.6B
$11.6M 0.13%
66,545
-153
-0.2% -$26.5K
TENB icon
200
Tenable Holdings
TENB
$3.6B
$11.4M 0.13%
299,974
-33,202
-10% -$1.22M

Similar funds

Segall Bryant & Hamill's Q4 2022 Portfolio in Review

As of Q4 2022, Segall Bryant & Hamill held 748 positions worth $8.96B, up 6.7% from $8.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill's Q4 2022 filing shows 26 new, 189 increased, 394 reduced and 36 closed positions. Its largest new stake was STAG Industrial: 847,354 shares worth $27.4M. The largest sale was CATALENT, INC., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Segall Bryant & Hamill's largest Q4 2022 buy was STAG Industrial: 847,354 shares worth $27.4M.
  • Segall Bryant & Hamill added most to Hancock Whitney in Q4 2022, an estimated $19.5M increase.
  • Segall Bryant & Hamill's biggest Q4 2022 reduction was CATALENT, INC., cutting an estimated $32.8M.
  • Segall Bryant & Hamill fully exited Avalara, Inc. in Q4 2022, selling an estimated $10.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $8.96B portfolio in Q4 2022.
  • Segall Bryant & Hamill opened 26 new positions and closed 36 in Q4 2022.
  • Segall Bryant & Hamill's portfolio value rose 6.7% quarter-over-quarter to $8.96B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.